AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (AGIO)

CUSIP: 00847X104

Q2 2024 13F Holders as of 30 Jun 2024

Holder snapshot 7 signals
Share change
-3,758,427
Put/Call ratio
107%
SEC-reported price per share
$43.12
Number of holders
203
Value change
-$125,225,015
Number of buys
95
Open additional details 1 more signal available
Number of sells
108
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
59,490,804

Security key

00847X104

Report period

Q2 2024

Institutions

203

Top holders

10

Ownership snapshot

Top reported holders of AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
FARALLON CAPITAL MANAGEME...
Disclosed value leader
FARALLON CAPITAL MANAGEME...
Comparable rows
15/15
Latest evidence
31 Mar 2024
13F Lead comparable stake: 9.4% Showing 1-6 of 15 holder rows.

Quick read

FARALLON CAPITAL MANAGEMENT LLC leads the comparable SEC ownership view at 9.4%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FARALLON CAPITAL MANAGEMENT LLC's linked filing trail.
Comparable ownership Top 5
FARALLON CAPITAL MANAGEMENT LLC 9.4%
VANGUARD GROUP INC 9.4%
BlackRock Finance, Inc. 7.8%
Bellevue Group AG 6.7%
STATE STREET CORP 5.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
FARALLON CAPITAL MANAGEMENT LLC
13F
Company
13F
9.4%
$163,469,202
5,590,602 shares
31 Mar 2024
VANGUARD GROUP INC
13F
Company
13F
9.4%
$162,925,894
5,572,021 shares
31 Mar 2024
BlackRock Finance, Inc.
13F
Company
13F
7.8%
$136,202,699
4,658,095 shares
31 Mar 2024
Bellevue Group AG
13F
Company
13F
6.7%
$117,135,440
4,006,000 shares
31 Mar 2024
STATE STREET CORP
13F
Company
13F
5.3%
$91,760,880
3,138,197 shares
31 Mar 2024
ARMISTICE CAPITAL, LLC
13F
Company
13F
5%
$86,667,360
2,964,000 shares
31 Mar 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
203
Shares
58,132,966
Rows available
203
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
183
Q2 2024 holders
203
Holder diff
20
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 value Q2 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .